Coldstream Laboratories Adds New VP of Operations
News Dec 13, 2010
In addition, Mr. Gelber will serve as a key advisor to Coldstream's CEO Larry Kranking. As a member of the company's executive leadership team, he will help drive the company's strategic growth.
"Mr. Gelber's depth of expertise in aseptic manufacturing will be an invaluable addition to the Coldstream team as we enter the company's next stage of growth," said Mr. Kranking. "Coldstream continues to grow and to expand the breadth of product types it manufactures. David brings to us a great deal of experience that will be invaluable in our efforts to continuously improve our performance. We are thrilled to have attracted such an experienced industry veteran to the Coldstream team."
Mr. Gelber brings over 25 years of experience in aseptic manufacturing, operations, and management, including nine years at Abbott and several other businesses in the injectable fill/finish manufacturing space. He began his career at Abbott in 1985 and took on levels of increasing responsibility throughout his career. These positions included Abbott's Small Volume Parenterals business unit as well as positions at Schein Pharmaceuticals, B.Braun Medical, aai Development Services, Hollister-Stier Laboratories, Galexe Pharma Sciences, and most recently Avrio Biopharmaceuticals, where he led manufacturing start-up activities for a new sterile contract manufacturing facility.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE